Stock listing
NASDAQ:EPRS EPIRUS Biopharmaceuticals Inc Stock
Follow EPIRUS Biopharmaceuticals Inc into a list and get an email when it puts out news.
Delisted NASDAQ:EPRS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:EPRS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Where EPIRUS Biopharmaceuticals Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EPRS · This page · Delisted | NASDAQ | United States | USD |
| OTC:EPRSQ · Delisted | OTC | United States | USD |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| J. Kevin Buchi Other companies: Benitec Biopharma Inc. (Director · Since at least Apr 15, 2020); Amneal Pharmaceuticals, Inc. (Director · Since at least May 4, 2018); Ampio Pharmaceuticals, Inc. (Director · Oct 13, 2021 – Jun 9, 2023 · Past); Alaunos Therapeutics, Inc. (Director · Sep 21, 2020 – Mar 4, 2021 · Past); BioSpecifics Technologies Corp (Chief Executive Officer, Director · Oct 8, 2019 – Oct 23, 2019 · Past); Dicerna Pharmaceuticals Inc (Director · Aug 13, 2018 – Dec 28, 2021 · Past); Impax Laboratories Inc (Director · Nov 23, 2016 – May 4, 2018 · Past); Tetralogic Pharmaceuticals Corp (President & CEO, Director · Dec 11, 2013 – Mar 26, 2015 · Past); Stemline Therapeutics Inc (Director · Jan 28, 2013 – Jun 23, 2015 · Past); Alexza Pharmaceuticals Inc (Director · Jan 2, 2013 – Jun 21, 2016 · Past); Encysive Pharmaceuticals Inc (Director · May 12, 2006 – Apr 1, 2008 · Past); Cephalon Inc (Chief Executive Officer, Director · Feb 17, 2006 – Oct 14, 2011 · Past) | Director · Jul 15, 2014 – Jun 5, 2015 · Past |
| Alexis Borisy Other companies: Parabilis Medicines, Inc. (Lead Independent Director; Chairman, Nextech Invest; Chairman, Curie.Bio · Since at least Jun 9, 2026); Tango Therapeutics, Inc. (Director · Since at least Aug 10, 2021); Relay Therapeutics, Inc. (Director · Since at least Jul 15, 2020); Revolution Medicines, Inc. (Director · Since at least Feb 12, 2020); Blueprint Medicines Corp (Director · Since at least Apr 30, 2015); OPKO Health, Inc. (Director · May 9, 2022 – Jun 22, 2023 · Past); EQRx Inc (Executive Chairman, Director · Dec 17, 2021 – Nov 9, 2023 · Past); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Aug 26, 2021 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Jun 15, 2017 · Past); Foundation Medicine Inc (Director · Sep 24, 2013 – Jul 31, 2018 · Past) | CEO & President, Director · Jan 26, 2006 – Jan 26, 2009 · Past |
| Mark Corrigan Other companies: Wave Life Sciences Ltd. (Director · Since at least Sep 4, 2019); Trevena, Inc. (Director · Jul 18, 2023 – Jun 13, 2024 · Past); Novelion Therapeutics Inc (Director · Mar 30, 2017 – Aug 9, 2018 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 2, 2022 · Past); CoLucid Pharmaceuticals Inc (Director · Oct 27, 2015 – Mar 1, 2017 · Past); Avanir Pharmaceuticals Inc (Director · Mar 18, 2014 – Mar 18, 2014 · Past); Cubist Pharmaceuticals Inc (Director · Jun 20, 2008 – Jan 21, 2015 · Past); Sepracor Inc (Executive VP, R&D · Mar 16, 2006 – Oct 20, 2009 · Past) | Director · Dec 21, 2009 – Jun 5, 2015 · Past |
| Amit Munshi Other companies: Arcutis Biotherapeutics, Inc. (Director · Since at least Dec 4, 2025); Inhibikase Therapeutics, Inc. (Board of Directors Chair, Inhibikase; Chief Executive Officer of Orna Therapeutics · Since at least Oct 21, 2024); Zura Bio Limited (Chairman · Since at least Mar 20, 2023); Damora Therapeutics, Inc. (Director · Since at least Oct 28, 2020); Social Capital Suvretta Holdings Corp IV (Director · Jun 29, 2021 – Jun 29, 2021 · Past); Pulmatrix, Inc. (Director · Jun 13, 2017 – Jan 28, 2021 · Past); Arena Pharmaceuticals Inc (President and CEO, Director · May 11, 2016 – Mar 11, 2022 · Past) | Chief Executive Officer, Director · Jul 15, 2014 – Feb 27, 2016 · Past |
| Todd Foley Other companies: Aktis Oncology, Inc. (Co-founder and Chairman · Since at least Jan 8, 2026); Entrada Therapeutics, Inc. (Director · Oct 28, 2021 – Jun 2, 2022 · Past); Turmeric Acquisition Corp (President · Oct 15, 2020 – Oct 15, 2020 · Past); Repare Therapeutics Inc (Director · Jun 18, 2020 – Jun 8, 2023 · Past); Rhythm Pharmaceuticals, Inc. (Director · Oct 4, 2017 – Mar 15, 2021 · Past); Chiasma Inc (Director · Jul 15, 2015 – Aug 5, 2021 · Past); Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Feb 4, 2014 · Past) | Director · Dec 21, 2009 – May 23, 2012 · Past |
| Michael Kauffman Other companies: Kyntra Bio, Inc. (Director · Since at least Jun 4, 2025); Kezar Life Sciences, Inc. (Director · Since at least Jun 20, 2018); Verastem, Inc. (President, Development · Since at least Nov 26, 2012); Adicet Bio, Inc. (Director · Nov 17, 2021 – Aug 21, 2024 · Past); Karyopharm Therapeutics Inc. (Director · Nov 5, 2013 – Feb 28, 2022 · Past); Onyx Pharmaceuticals Inc (Chief Medical Officer · Nov 16, 2009 – Feb 9, 2010 · Past) | Director · Jan 15, 2010 – Jun 6, 2013 · Past |
| Sally Crawford Other companies: ZimVie Inc (Director · Since at least Mar 1, 2022); Universal American Corp (Director · Jun 4, 2009 – Apr 28, 2017 · Past); Insulet Corporation (Director · Oct 17, 2008 – Jun 4, 2021 · Past); Hologic Inc (Director · Oct 22, 2007 – Mar 7, 2024 · Past); EXACT Sciences Corporation (Director · Jul 21, 2006 – Oct 16, 2014 · Past); Cytyc Corp (Director · Jan 1, 2006 – Oct 22, 2007 · Past) | Director · May 31, 2007 – Jun 6, 2013 · Past |
| Scott M Rocklage Other companies: Aprea Therapeutics, Inc. (Director · Oct 2, 2019 – Jun 30, 2020 · Past); Pulmatrix, Inc. (Director · Jun 15, 2015 – Feb 3, 2016 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 13, 2018 · Past); Achaogen Inc (Director · Mar 11, 2014 – Mar 11, 2014 · Past); Relypsa Inc (Director · Nov 14, 2013 – Nov 20, 2013 · Past) | Director · Jul 15, 2014 – Jun 5, 2015 · Past |
| Frank Haydu Other companies: Moldflow Corp (Director · Nov 27, 2006 – Jun 25, 2008 · Past); Iparty Corp (Director · Jun 7, 2006 – May 9, 2013 · Past); Albany Molecular Research Inc (Director · Jun 1, 2006 – Jun 1, 2006 · Past) | Director · Jun 1, 2006 – Jun 6, 2013 · Past |
| Geoffrey M Duyk Other companies: Aerie Pharmaceuticals Inc. (Director · Oct 25, 2013 – Feb 14, 2017 · Past); Amyris Inc (Director · Sep 27, 2010 – May 7, 2024 · Past); Cardiovascular Systems Inc (Director · Jun 27, 2006 – May 8, 2008 · Past) | Director · Jul 15, 2014 – Jun 5, 2015 · Past |
All 27 people
| Person | Seat |
|---|---|
| Justin Renz Other companies: Zevra Therapeutics, Inc. (Chief Financial Officer · Since at least Mar 5, 2026); Ardelyx, Inc. (Chief Financial Officer · Since at least Jun 8, 2020); Karyopharm Therapeutics Inc. (EVP, CFO & Treasurer · Aug 18, 2014 – Jan 20, 2017 · Past) | EVP, CFO & Treasurer · Jul 1, 2009 – Feb 10, 2014 · Past |
| Robert Forrester Other companies: Immunomedics Inc (Director · Jan 8, 2017 – Jan 8, 2017 · Past); Verastem, Inc. (President and CEO, Director · Jan 26, 2012 – Jan 3, 2019 · Past); Myrexis Inc (Director · Nov 11, 2010 – Dec 8, 2011 · Past) | EVP and COO, Director · May 14, 2007 – Dec 21, 2009 · Past |
| Vincent Aurentz Other companies: Inhibikase Therapeutics, Inc. (Director · Since at least Feb 21, 2025); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); Arena Pharmaceuticals Inc (Executive VP and CBO · Aug 15, 2016 – Mar 11, 2022 · Past) | Chief Business Officer · Nov 9, 2015 – May 27, 2016 · Past |
| Thomas A Shea Other companies: Albireo Pharma Inc (CFO and Treasurer · Nov 3, 2016 – Jun 8, 2018 · Past); NxStage Medical Inc (SVP Manufacturing Operations · Mar 31, 2008 – Sep 9, 2013 · Past) | Chief Financial Officer · Jul 15, 2014 – May 27, 2016 · Past |
| Barbara Deptula Other companies: AMAG Pharmaceuticals Inc (Director · Sep 6, 2013 – May 16, 2019 · Past) | Director · Jun 1, 2006 – May 29, 2008 · Past |
| Daniel Grau Other companies: POINT Biopharma Global Inc (Director · Jul 7, 2020 – Jul 7, 2020 · Past) | Chief Operating Officer · Jan 1, 2006 – Jan 26, 2008 · Past |
| Hartley T Richardson Other companies: Angiotech Pharmaceuticals Inc (Director · Mar 31, 2008 – Jun 4, 2009 · Past) | Director · Dec 21, 2009 – May 24, 2011 · Past |
| Jason Cole Other companies: Bluebird bio Inc (Chief Strategy & Financial Off · Mar 7, 2014 – Aug 19, 2022 · Past) | EVP,Corp Dev & General Counsel · Jan 23, 2006 – Jan 3, 2013 · Past |
| Patrick J Fortune Other companies: PAREXEL International Corp (Director · Feb 21, 2006 – Sep 29, 2017 · Past) | Director · Jun 1, 2006 – May 29, 2008 · Past |
| Robert Ticktin Other companies: PMV Pharmaceuticals, Inc. (General Counsel & COO · Since at least Apr 21, 2025) | General Counsel · Jul 15, 2014 – May 27, 2016 · Past |
| William L Hunter Other companies: Angiotech Pharmaceuticals Inc (CEO & President, Director · Mar 31, 2008 – May 12, 2011 · Past) | Director · Dec 21, 2009 – Jun 5, 2015 · Past |
| C Eugene Wright | SVP & Chief Dev Officer · Dec 21, 2009 – Mar 1, 2010 · Past |
| Christopher C Gallen | EVP Research & Development · Dec 21, 2009 – Feb 29, 2012 · Past |
| Jan Lessem | Executive VP & CMO · Jan 26, 2006 – Sep 15, 2006 · Past |
| John Randle | SVP Commercial Development · Jan 15, 2008 – Jul 15, 2008 · Past |
| Kim Seth | Chief Business Officer · Jul 15, 2014 – Jul 15, 2014 · Past |
| Michael Wyand | President and COO · Sep 14, 2015 – May 27, 2016 · Past |
Log in to ask 6ix AI your own questions about EPIRUS Biopharmaceuticals Inc.